A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS)
r-hFSH alfa originator is cost-effective compared to its biosimilars and to urinaries (mainly HP-hMG) and is associated with a lower cost per LB compared to these gonadotropins, where the main driver is the higher LB efficacy rate achieved with it.
Authors
- Claudia Roeder
- Gerard Harty (ORCID: https://orcid.org/0000-0002-1986-4760)
- Thomas D'Hooghe
- Mehdi Benchaïb (ORCID: https://orcid.org/0000-0001-5250-6036)
- Juan-Enrique Schwarze (ORCID: https://orcid.org/0000-0001-8988-521X)
- Isabelle Borget (ORCID: https://orcid.org/0000-0002-6295-6361)
- Isabelle Cedrin Durnerin
- Vivek Chaudhari (ORCID: https://orcid.org/0000-0002-5286-9213)
- Michaël Grynberg
- L. Rey
- Philippine Poignant
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Merck KGaA, Darmstadt (Germany) (DE)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- La Ligue Contre le Cancer (FR)
- Hospices Civils de Lyon (FR)
- Hôpitaux Universitaires Paris-Ouest (FR)
- Laboratoire de Biométrie et Biologie Evolutive (FR)
- IQVIA (France) (FR)
- Hôpital Jean-Verdier (FR)
- Hôpital Antoine-Béclère (FR)
- École nationale supérieure des sciences de l'information et des bibliothèques (FR)
Publication Details
- Journal
- Gynecologic and Obstetric Investigation
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1159/000542074
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Merck KGaA